Abstract
In this study, histopathological and biochemical changes due to chronic usage of morphine or tramadol in liver and kidney were assessed in rats. Thirty male Wistar rats (180–220 g) were included and divided into three groups. Normal saline (1 ml) was given intraperitoneally as placebo in the control group (n = 10). Morphine group (n = 10) received morphine intraperitoneally at a dose of 4, 8, 10 mg/kg/day in the first, second and the third ten days of the study, respectively. Tramadol group (n = 10), received the drug intraperitoneally at doses of 20, 40 and 80 mg/kg/day in the first, second and the third ten days of the study, respectively. Aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), creatinin, blood urea nitrogen (BUN) and malondialdehyde (MDA) levels were measured in the serum. Liver and kidney specimens were evaluated by light microscopy. Serum ALT, AST, LDH, BUN and creatinin levels were significantly higher in morphine group compared to the control group. Serum LDH, BUN and creatinin levels were significantly increased in the morphine group compared to the tramadol group. The mean MDA level was significantly higher in morphine group compared to the tramadol and control groups (P<0.05). Light microscopy revealed severe centrolobular congestion and focal necrosis in the liver of morphine and tramadol groups, but perivenular necrosis was present only in the morphine group. The main histopathologic finding was vacuolization in tubular cells in morphine and tramadol groups. Our findings pointed out the risk of increased lipid peroxidation, hepatic and renal damage due to long term use of opioids, especially morphine. Although opioids are reported to be effective in pain management, their toxic effects should be kept in mind during chronic usage
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- ALT:
-
Alanine aminotransferase
- AST:
-
aspartate aminotransferase
- BUN:
-
blood urea nitrogen
- LAAM:
-
levoalpha-acetylmethadol
- LDH:
-
lactate dehydrogenase
- MDA:
-
malondialdehyde
References
Bannwarth B 1999 Risk-benefit assessment of opioids in chronic noncancer pain;Drug Saf. 21 283–296
Borzelleca J F, Egle J L Jr, Harris L S, Johnson D N, Terrill J B and Belleville J A 1994 Toxicological evaluation of mu-ago-nists. Part I: Assessment of toxicity following 30 days of repeated oral dosing of male and female rats with levo-alpha-acetylmethadol HCL (LAAM);J. Appl. Toxicol. 14 435–446
Brena S F and Sander S H 1991 Opioids in non-malignant pain: questions in search of answers;Clin. J. Pain 7 342–345
Collet B J 2001 Chronic opioid therapy for non-cancer pain;Br. J. Anaesth. 87 133–143
Coughtrie M W, Ask B, Rane A, Burchell B and Hume R 1989 The enantioselective glucuronidation of morphine in rats and humans. Evidence for the involvement of more than one UDP-glucuronosyltransferase isoenzyme;Biochem. Pharmacol. 38 3273–3280
Gomez-Lechon M J, Ponsoda X, Jover R, Fabra R, Trullenque R and Castell J V 1988 Hepatotoxicity of the opioids morphine, heroin, meperidine, and methadone to cultured human hepatocytes;Mol. Toxicol. 1 453–463
Lee R C, McTavish, Sorkin E M 1993 Tramadol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states;Drugs 46 313–340
Lurie E, Soloviova A, Alyabieva T, Kaplun A, Panchenko L and Shvets V 1995 Effect of novel aromatic derivative of GABA on lipid peroxidation in chronically morphinized rats;Biochem. Mol. Biol. Int. 36 13–19
Masini A, Gallesi D, Giovannini F, Trenti T and Ceccarelli D 1997 Membrane potential of hepatic mitochondria after acute cocaine administration in rats — the role of mitochondrial reduced glutathione;Hepatology 25 385–390
Matthiessen T, Wöhrmann T, Coogan T P and Uragg H 1998 The experimental toxicology of tramadol: an overview;Toxicol. Lett. 95 63–71
McCarberg B H and Barkin R L 2001 Long-acting opioids for chronic pain: pharmacotherapeutic opportunities to enhance compliance, quality of life, and analgesia;Am. J. Ther. 8 181–186
Milne R W, McLean C F, Mather L E, Nation R L, Runciman W B, Rutten A J and Somogyu A A 1997 Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine;J. Pharmacol. Exp. Ther. 282 779–786
Nagmatsu K, Onho Y, Ikebuchi H, Takahashi A, Terao T and Takanaka A 1986 Morphine metabolism in isolated rat hepatocytes and its implications for hepatotoxicity;Biochem. Pharmacol. 35 3543–3548
Ohkawa H, Ohishi N and Yagi K 1979 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction;Anal. Biochem. 95 351
Pacifici G M, Bencini C and Rane A 1986 Presystemic glucuronidation of morphine in humans and rhesus monkeys: subcellular distribution of the UDP-glucuronyltransferase in the liver and intestine;Xenobiotica 16 123–128
Panchenko L F, Pirozhkov S V, Nadezhdin A V, Baronets V I and Usmanova N N 1999 Lipid peroxidation, peroxyl radicalscavenging system of plasma and liver and heart pathology in adolescence heroin users;Vopr. Med. Khim. 45 501–506
Poppers P J 1980 Hepatic drug metabolism and anesthesia;Anaesthesist 29 55–58
Portenoy K R and Foley K M 1986 Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases;Pain 25 171–186
Quang-Cantagrel N D, Wallace M S and Magnuson S K 2000 Opioid substitution to improve the effectiveness of chronic noncancer pain control a chart review;Anesth. Analg. 90 933–937
Singhal P C, Sharma P, Sanwal V, Prassad A, Kapasi A, Ranjan R, Franki N, Reddy K and Gibbons N 1998 Morphine modulates proliferation of kidney fibroblasts;Kidney Int. 53 350–357
Stain-Texier F, Sandouk P and Scherrann J M 1998 Intestinal absorption and stability of morphine 6-glucuronide in different physiological compartments of the rat;Drug. Metab. Dispos. 26 383–387
Tao Q, Stone D J, Borenstein M R, Codd E E and Coogan T P 2002 Differential tramadol and O-desmethyl metabolite levels in brain vs plasma of mice and rats administered tramadol hydrochloride orally;J. Clin. Pharm. Therap. 27 99–106
Tolman K G 1998 Hepatotoxicity of non-narcotic analgesics;Am. J. Med. 105 13S-19S
Turk D C, Brody M C and Okifuji E A 1994 Physicians’ attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain;Pain 59 201–208
Van der Laan J W, Krajnc-Franken M A and van Loveren H 1995 Immunotoxicological screening of morphine and methadone in an extended 28 day study in rats;Int. J. Immunopharmacol. 17 535–543
William S, Sekar N, Subramanian S and Govindasamy S 1991 Toxic effect of morphine and the antagonistic role of naloxone on isolated rat hepatocytes;Biochem. Int. 23 1071–1077
Wu W N, McKnown L A, Gauthier A D, Jones W J and Raffa R B 2001 Metabolism of the analgesic, tramadol hydrochloride, in rat and dog;Xenobiotica 31 423–441
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Atici, S., Cinel, I., Cinel, L. et al. Liver and kidney toxicity in chronic use of opioids: An experimental long term treatment model. J. Biosci. 30, 245–252 (2005). https://doi.org/10.1007/BF02703705
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02703705